A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma

Background: Cuprotosis is a recently discovered copper-dependent cell death mechanism that relies on mitochondrial respiration. However, the role of cuprotosis-related genes (CRGs) in hepatocellular carcinoma (HCC) and their prognostic significances remain unknown.Methods: Based on the recently publ...

Full description

Bibliographic Details
Main Authors:	Ruo-Nan Shao, Kun-Hao Bai, Qian-Qian Huang, Si-Liang Chen, Xin Huang, Yu-Jun Dai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	cuprotosis (CRGs) prognostic model hepatocellular carcinoma (HCC) treg cells immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2023.1180625/full

Similar Items

Expression and Prognostic Value of Cuprotosis-related Genes in Liver Cancer
by: ZHAO Xiaole, et al.
Published: (2023-02-01)

Five cuprotosis-related lncRNA signatures for prognosis prediction in acute myeloid leukaemia
by: Qian Wang
Published: (2023-12-01)

Construction of Prognostic Model for Cuprotosis in Hepatocellular Carcinoma Based on TCGA Database
by: LEI Qingsong, et al.
Published: (2023-03-01)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
by: Jingjing Xiao, et al.
Published: (2022-08-01)

Construction of a model for predicting the prognosis of liver cancer patients based on CuProtosis-related LncRNA
by: Yiyang Chen, et al.
Published: (2022-10-01)

Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients
by: Hao Chi, et al.
Published: (2022-10-01)

A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer
by: Wei Li, et al.
Published: (2022-11-01)

Systematic analysis of the cuprotosis in tumor microenvironment and prognosis of gastric cancer
by: Ke-wei Wang, et al.
Published: (2023-03-01)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
by: Fan Zhang, et al.
Published: (2022-09-01)

Machine learning-based characterization of cuprotosis-related biomarkers and immune infiltration in Parkinson’s disease
by: Songyun Zhao, et al.
Published: (2022-10-01)

FDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis
by: Gaoxiang Chen, et al.
Published: (2023-08-01)

Estimating disease-free survival of thyroid cancer based on novel cuprotosis-related gene model
by: Rui Du, et al.
Published: (2023-09-01)

Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer
by: Ximo Xu, et al.
Published: (2023-03-01)

Identification of core cuprotosis-correlated biomarkers in abdominal aortic aneurysm immune microenvironment based on bioinformatics
by: Jiateng Hu, et al.
Published: (2023-04-01)

Integrative analysis of bioinformatics and machine learning to identify cuprotosis-related biomarkers and immunological characteristics in heart failure
by: Dingyuan Tu, et al.
Published: (2024-03-01)

Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes
by: Guangyao Wang, et al.
Published: (2023-02-01)

Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions
by: Guoming Chen, et al.
Published: (2023-06-01)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
by: Zhijian Wang, et al.
Published: (2023-08-01)

Deciphering the molecular classification of pediatric sepsis: integrating WGCNA and machine learning-based classification with immune signatures for the development of an advanced diagnostic model
by: Junming Huang, et al.
Published: (2024-01-01)

Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression
by: Helal F. Hetta, et al.
Published: (2020-07-01)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
by: Yuan Yang, et al.
Published: (2021-06-01)

Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
by: Zhonghao Wang, et al.
Published: (2017-07-01)

TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
by: Yinan Shen, et al.
Published: (2015-03-01)

Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes
by: Lei Wang, et al.
Published: (2022-12-01)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
by: Yang Chen, et al.
Published: (2023-04-01)

m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma
by: Xin-Yu Li, et al.
Published: (2022-05-01)

MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A
by: Wenyue Zhao, et al.
Published: (2022-01-01)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
by: Pian Li, et al.
Published: (2022-10-01)

MUTYH is a potential prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
by: Fan Yang, et al.
Published: (2022-12-01)

The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
by: Qian Qiao, et al.
Published: (2023-10-01)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
by: Zheng Zhou, et al.
Published: (2022-12-01)

Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment
by: Genhao Zhang
Published: (2022-09-01)

The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
by: Jie Zhu, et al.
Published: (2021-11-01)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
by: Ze-Bing Song, et al.
Published: (2021-10-01)

A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma
by: Dezhao Lin, et al.
Published: (2023-01-01)

Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment
by: Lior Charach, et al.
Published: (2018-06-01)

Transgenic zebrafish for modeling hepatocellular carcinoma
by: Joji Nakayama, et al.
Published: (2020-09-01)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
by: Li Zhang, et al.
Published: (2022-11-01)

Prognostic iron-metabolism signature robustly stratifies single-cell characteristics of hepatocellular carcinoma
by: Zhipeng Zhu, et al.
Published: (2024-12-01)

Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology
by: Lior Charach,, et al.
Published: (2017-06-01)